Dashboard

Financial News

NYT Strands Hints, Answers For February 27, 2026
in_mashable37d ago

NYT Strands Hints, Answers For February 27, 2026

Every hint, nudge and outright answer you need to complete today's NYT Strands puzzle.Today's NYT Strands hints are easy if you tend to overdo it.Strands, the New York Times' elevated word-search game, requires the player to perform a twist on the classic word search. Words can be made from linked letters — up, down, left, right, or diagonal, but words ...

#TECH
GSE Crosses GH¢230 Billion as Index Hits 12,534 on Thursday
newsghana37d ago

GSE Crosses GH¢230 Billion as Index Hits 12,534 on Thursday

News Ghana, Latest Updates and Breaking News of Ghana, Roger A. Agana, https://www.newsghana.com.gh/gse-crosses-gh%c2%a2230-billion-as-index-hits-12534-on-thursday/Ghana’s stock market pushed into new territory on Thursday, February 26, 2026, with the Ghana Stock Exchange Composite Index (GSE-CI) surging 274.78 points to close the 7,162nd trading session at 12,534.31, lifting total market capitalisation to GH¢230.25 billion — the highest level the exchange has ever recorded. The benchmark index advanced 2.24 percent from Wednesday’s [...] News Ghana, Latest Updates and Breaking News of Ghana, Roger A. Agana, https://www.newsghana.com.gh/gse-crosses-gh%c2%a2230-billion-as-index-hits-12534-on-thursday/

#STOCKS
Liberty Media Corporation – Liberty Live Series A (NASDAQ:LLYVA) Announces Earnings Results, Beats Expectations By $1,000.24 EPS
themarketsdaily37d ago

Liberty Media Corporation – Liberty Live Series A (NASDAQ:LLYVA) Announces Earnings Results, Beats Expectations By $1,000.24 EPS

Liberty Media Corporation – Liberty Live Series A (NASDAQ:LLYVA – Get Free Report) issued its quarterly earnings data on Thursday. The company reported $999.00 earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.24) by $1,000.24, Zacks reports. Liberty Media Corporation – Liberty Live Series A Stock Up 2.1% LLYVA traded up [...]

#STOCKS
Heron Therapeutics (NASDAQ:HRTX) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS
themarketsdaily37d ago

Heron Therapeutics (NASDAQ:HRTX) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Heron Therapeutics (NASDAQ:HRTX – Get Free Report) posted its quarterly earnings data on Thursday. The biotechnology company reported ($0.02) EPS for the quarter, beating analysts’ consensus estimates of ($0.03) by $0.01, FiscalAI reports. The company had revenue of $40.59 million for the quarter, compared to analyst estimates of $39.53 million. Here are the key takeaways [...]

#STOCKS
Structure Therapeutics (NASDAQ:GPCR) Posts Quarterly Earnings Results, Beats Estimates By $999.35 EPS
thelincolnianonline37d ago

Structure Therapeutics (NASDAQ:GPCR) Posts Quarterly Earnings Results, Beats Estimates By $999.35 EPS

Structure Therapeutics (NASDAQ:GPCR – Get Free Report) posted its quarterly earnings data on Thursday. The company reported $999.00 EPS for the quarter, beating the consensus estimate of ($0.35) by $999.35, reports. Structure Therapeutics Stock Performance NASDAQ GPCR traded down $1.78 during trading hours on Thursday, hitting $64.75. The company had a trading volume of 939,537 [...]

#STOCKS
Ligand Pharmaceuticals (NASDAQ:LGND) Releases Quarterly Earnings Results, Beats Expectations By $0.56 EPS
thelincolnianonline37d ago

Ligand Pharmaceuticals (NASDAQ:LGND) Releases Quarterly Earnings Results, Beats Expectations By $0.56 EPS

Ligand Pharmaceuticals (NASDAQ:LGND – Get Free Report) announced its quarterly earnings results on Thursday. The biotechnology company reported $2.02 earnings per share for the quarter, beating analysts’ consensus estimates of $1.46 by $0.56, FiscalAI reports. Ligand Pharmaceuticals had a net margin of 19.34% and a return on equity of 5.71%. The company had revenue of [...]

#STOCKS
Kymera Therapeutics (NASDAQ:KYMR) Issues Quarterly Earnings Results
watchlistnews37d ago

Kymera Therapeutics (NASDAQ:KYMR) Issues Quarterly Earnings Results

Kymera Therapeutics (NASDAQ:KYMR – Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.97) earnings per share for the quarter, missing the consensus estimate of ($0.77) by ($0.20), FiscalAI reports. The business had revenue of $2.87 million for the quarter, compared to analyst estimates of $14.80 million. Kymera Therapeutics had a [...]

#STOCKS